Swisstek (Ceylon) Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Swisstek (Ceylon) şirketinin toplam hissedar öz sermayesi LKR2.7B ve toplam borcu LKR6.4B olup, bu da borç-öz sermaye oranını 236.9% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla LKR12.0B ve LKR9.3B dir. Swisstek (Ceylon) 'in FAVÖK'ü LKR1.2B faiz karşılama oranı 3.4 dur. Şirketin LKR419.1M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

236.9%

Borç/özkaynak oranı

LK₨6.35b

Borç

Faiz karşılama oranı	3.4x
Nakit	LK₨419.13m
Eşitlik	LK₨2.68b
Toplam yükümlülükler	LK₨9.34b
Toplam varlıklar	LK₨12.03b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: PARQ.N0000 'nin kısa vadeli varlıkları ( LKR7.6B ) kısa vadeli yükümlülüklerini ( LKR6.7B ) aşıyor.

Uzun Vadeli Yükümlülükler: PARQ.N0000 şirketinin kısa vadeli varlıkları ( LKR7.6B ) uzun vadeli yükümlülüklerini ( LKR2.6B ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: PARQ.N0000 'nin net borç/öz sermaye oranı ( 221.3% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: PARQ.N0000 şirketinin borç/öz sermaye oranı son 5 yılda 150.1% seviyesinden 236.9% seviyesine yükseldi.

Borç Kapsamı: PARQ.N0000 'nin borcu işletme nakit akışı ( 3.4% ) tarafından iyi bir şekilde karşılanmıyor.

Faiz Kapsamı: PARQ.N0000 'in borcuna ilişkin faiz ödemeleri EBIT ( 3.4 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.

Swisstek (Ceylon) Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Second quarter 2025 earnings released: EPS: LK₨1.63 (vs LK₨0.055 in 2Q 2024)

Investor sentiment improves as stock rises 18%

MD & Executive Director recently bought LK₨2.0m worth of stock

Investor sentiment improves as stock rises 18%

First quarter 2025 earnings released: EPS: LK₨0.58 (vs LK₨1.16 loss in 1Q 2024)

Upcoming dividend of LK₨0.30 per share

Full year 2024 earnings released: LK₨0.51 loss per share (vs LK₨4.15 loss in FY 2023)

Dividend of LK₨0.30 announced

New minor risk - Share price stability

Upcoming dividend of LK₨0.50 per share

Dividend reduced to LK₨0.50

Third quarter 2024 earnings released: LK₨0.43 loss per share (vs LK₨1.99 loss in 3Q 2023)

Second quarter 2024 earnings released: LK₨0.16 loss per share (vs LK₨0.12 profit in 2Q 2023)

New major risk - Revenue and earnings growth

First quarter 2024 earnings released: LK₨1.16 loss per share (vs LK₨0.28 loss in 1Q 2023)

Upcoming dividend of LK₨0.20 per share at 7.7% yield

Swisstek (Ceylon) PLC, Annual General Meeting, Jun 30, 2023

Swisstek (Ceylon) plc Proposes Final Dividend

Full year 2023 earnings released: LK₨4.15 loss per share (vs LK₨6.16 profit in FY 2022)

MD & Executive Director recently bought LK₨463k worth of stock

Third quarter 2023 earnings released: LK₨1.99 loss per share (vs LK₨2.41 profit in 3Q 2022)

Insufficient new directors

Second quarter 2023 earnings released: EPS: LK₨0.12 (vs LK₨1.40 in 2Q 2022)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Director recently bought LK₨4.3m worth of stock

First quarter 2023 earnings released: LK₨0.28 loss per share (vs LK₨0.49 profit in 1Q 2022)

Investor sentiment improved over the past week

MD & Executive Director recently bought LK₨274k worth of stock

Investor sentiment improved over the past week

Swisstek (Ceylon) PLC, Annual General Meeting, Jun 29, 2022

Upcoming dividend of LK₨0.90 per share

Full year 2022 earnings released: EPS: LK₨6.16 (vs LK₨4.37 in FY 2021)

Investor sentiment improved over the past week

MD & Executive Director recently bought LK₨150k worth of stock

Investor sentiment deteriorated over the past week

Insufficient new directors

Insufficient new directors

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Upcoming dividend of LK₨1.00 per share

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

MD & Executive Director recently bought LK₨232k worth of stock

Director recently sold LK₨16m worth of stock

Director recently sold LK₨16m worth of stock

Investor sentiment improved over the past week

Second quarter 2022 earnings released

Upcoming dividend of LK₨0.80 per share

Director recently bought LK₨7.0m worth of stock

First quarter 2022 earnings released: EPS LK₨0.49 (vs LK₨0.21 loss in 1Q 2021)

Full year 2021 earnings released: EPS LK₨4.37 (vs LK₨1.26 in FY 2020)

Investor sentiment deteriorated over the past week

Director recently sold LK₨12m worth of stock

Upcoming Dividend of LK₨4.10 Per Share

Third quarter 2021 earnings released: EPS LK₨6.04 (vs LK₨2.28 in 3Q 2020)

Investor sentiment improved over the past week

New 90-day high: LK₨141

New 90-day high: LK₨101

New 90-day high: LK₨85.20

Director recently sold LK₨8.0m worth of stock

Market bids up stock over the past week

Second quarter 2021 earnings released: EPS LK₨5.51

New 90-day high: LK₨68.20

Market bids up stock over the past week

MD & Executive Director recently bought LK₨817k worth of stock

Market bids up stock over the past week

New 90-day high: LK₨51.10

New 90-day high: LK₨46.50

New 90-day high - LK₨43.50

First quarter earnings released

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin